Coloplast A/S experienced notable insider activity in March 2026, with three executives and board members acquiring shares. CFO Anders Lonning-Skovgaard, alongside directors Niels B. Christiansen and Carsten Hellmann, executed purchases totaling approximately 5 million DKK. These transactions represent the most recent internal equity movements recorded for the organization.